OECD TG 415 is the “One-Generation Reproduction Toxicity Study ” standard, which is included in Section 4 (Health Effects) of the OECD Test Guidelines for the Testing of Chemicals. The test is designed to evaluate the effects of a test substance on male and female reproductive functions, pregnancy, birth, lactation, and the development of offspring over a single generation.
Note on Regulatory Status: OECD TG 415 has been superseded by the OECD and largely replaced by OECD TG 443 (Extended One-Generation Reproductive Toxicity Study, EOGRTS). Nevertheless, TG 415 continues to be used as a reference in certain regulatory frameworks for the evaluation of older dossiers and the interpretation of historical data sets. For this reason, the service page covers both the scientific content of the guideline and its current practical application.
The basic principle of the test is to administer the test substance to male and female animals starting before mating, to allow them to mate, and to observe the stages of pregnancy, birth, and lactation. The evaluation is typically conducted on rats. The offspring are monitored for developmental progress until weaning.
The basic parameters evaluated in the study are as follows:
Parent Generation (P) – Reproductive Function:
- Gonadal Function and the Estrus Cycle
- Mating Behavior and Mating Index
- Fertility and Conception Rates
- Sperm parameters (count, motility, morphology)
- Histopathological Examination of the Reproductive Organs
Pregnancy and Childbirth:
- Gestation Period and Gestation Index
- Course of Labor and Live Birth Rate
- Data on Resorption, Stillbirths, and Implantation
Next Generation (F1):
- Live births and survival after birth
- Body Weight and Growth Curve
- Indicators of Physical Development
- Clinical Observations Prior to Weaning
- If applicable, record the gender distribution and any developmental abnormalities
The study design includes a negative control group, a solvent control group, and, if applicable, a positive control group; dosages, group size, and duration of administration are justified in accordance with the regulatory requirements of OECD TG 415.
Why is this study being conducted?
The OECD TG 415 is being conducted for the following scientific and regulatory purposes:
Assessment of Reproductive Toxicity: Determination of the Effects of the Test Substance on Male and Female Fertility
Assessment of developmental effects: Identification of effects occurring during pregnancy, birth, and lactation
Monitoring Offspring Development: Evaluation of Postnatal Survival and Growth Parameters in the F1 Generation
Support for Regulatory Submissions: Use in Safety Assessments of Chemicals, Pesticides, Biocidal Products, and Industrial Chemicals
Analysis of Historical Data: Evaluation of Existing TG 415 Studies in the Current Regulatory Context and Comparison with TG 443 Data
The “Weight-of-Evidence” Approach: A Contribution to Risk Assessment in Conjunction with Other Data on Reproductive and Developmental Toxicity, Physicochemical Properties, and Exposure Assessment
OECD Test Guideline 415 does not, on its own, cover the entire reproductive toxicity profile. Its informative value is limited with regard to transgenerational effects, functional developmental endpoints, and endocrine effects; therefore, current regulatory assessments rely on Test Guideline 443 and the associated guidelines. The results should be interpreted within the context of a comprehensive toxicological assessment.
As part of our nano-testing services, we conduct analyses in accordance with OECD TG 415 as well as the procedures outlined in OECD TG 443—the current equivalent of this standard—with scientific rigor within our accredited laboratory infrastructure and quality management system. Our scope of services includes the following:
Experimental Design and Protocol Development
Preparation of a test report in accordance with OECD TG 415 and its current equivalent, OECD TG 443
Determination of the dosage range and establishment of the main experimental design based on the physicochemical properties of the test substance
Identification of negative controls, solvent controls, and, where appropriate, suitable positive control groups; scientific justification for the selection of species, route of administration, dosage levels, and duration of treatment; compliance with requirements regarding ethical approvals and animal welfare
For your studies conducted in accordance with OECD TG 415 and its current counterpart, OECD TG 443, you can contact Nano-Test to obtain information on study design, species selection, sample acceptance criteria, testing schedules, and reporting processes. We also offer scientific consulting to help you evaluate your existing TG 415 data within the current regulatory context and to develop a strategy for transitioning to TG 443.